[
  {
    "ts": null,
    "headline": "Merck & Co., Inc. (MRK): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Jimmy Investor. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)’s share was trading at $94.79 as of March 17th. MRK’s trailing and forward P/E were 14.06 and 10.53 respectively according to Yahoo Finance. Merck […]",
    "url": "https://finnhub.io/api/news?id=ed39a9a1c8dc7051468cbcfd7b6c5fd5363b68876e283d18a6c7c40fec8ba9f5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742325533,
      "headline": "Merck & Co., Inc. (MRK): A Bull Case Theory",
      "id": 133324752,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Jimmy Investor. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)’s share was trading at $94.79 as of March 17th. MRK’s trailing and forward P/E were 14.06 and 10.53 respectively according to Yahoo Finance. Merck […]",
      "url": "https://finnhub.io/api/news?id=ed39a9a1c8dc7051468cbcfd7b6c5fd5363b68876e283d18a6c7c40fec8ba9f5"
    }
  },
  {
    "ts": null,
    "headline": "Big pharma fears best-selling drugs in crosshairs of US-EU tariff spat",
    "summary": "Drugmakers are urging theTrump administration and European Union officials to excludemedical goods from expanding tariff wars, hoping to avert pricespikes on top-selling medicines made in Europe...",
    "url": "https://finnhub.io/api/news?id=56ad5b5955a0853042e2a6c2168cef8a906df0b65012b19d8e3c172089dd5907",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742303188,
      "headline": "Big pharma fears best-selling drugs in crosshairs of US-EU tariff spat",
      "id": 133230668,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Drugmakers are urging theTrump administration and European Union officials to excludemedical goods from expanding tariff wars, hoping to avert pricespikes on top-selling medicines made in Europe...",
      "url": "https://finnhub.io/api/news?id=56ad5b5955a0853042e2a6c2168cef8a906df0b65012b19d8e3c172089dd5907"
    }
  },
  {
    "ts": null,
    "headline": "Is Merck & Co Inc. (NYSE:MRK) the Most Undervalued S&P 500 Stock to Buy Now?",
    "summary": "We recently published a list of 10 Most Undervalued S&P 500 Stocks to Buy Now. In this article, we are going to take a look at where Merck & Co Inc. (NYSE:MRK) stands against other undervalued S&P 500 stocks to buy now. Earlier on March 13, Michael Cuggino, President and Portfolio Manager of the Permanent […]",
    "url": "https://finnhub.io/api/news?id=e8d224b0994927a3e6635988e4d167b2192ca212565f1d2bc7101cdd8f74d280",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742302016,
      "headline": "Is Merck & Co Inc. (NYSE:MRK) the Most Undervalued S&P 500 Stock to Buy Now?",
      "id": 133324753,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "We recently published a list of 10 Most Undervalued S&P 500 Stocks to Buy Now. In this article, we are going to take a look at where Merck & Co Inc. (NYSE:MRK) stands against other undervalued S&P 500 stocks to buy now. Earlier on March 13, Michael Cuggino, President and Portfolio Manager of the Permanent […]",
      "url": "https://finnhub.io/api/news?id=e8d224b0994927a3e6635988e4d167b2192ca212565f1d2bc7101cdd8f74d280"
    }
  },
  {
    "ts": null,
    "headline": "Levi & Korsinsky Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK",
    "summary": "NEW YORK, March 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. of a class action securities lawsuit. ...",
    "url": "https://finnhub.io/api/news?id=28df1e61f810e32f8cfaf1a57676a0edff1f73feb9f9e19bb82aa41b66953f64",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742276783,
      "headline": "Levi & Korsinsky Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK",
      "id": 133214586,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "NEW YORK, March 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. of a class action securities lawsuit. ...",
      "url": "https://finnhub.io/api/news?id=28df1e61f810e32f8cfaf1a57676a0edff1f73feb9f9e19bb82aa41b66953f64"
    }
  }
]